Regional effects of verapamil on recovery of excitability and conduction time in experimental ischemia.
- 1 November 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 76 (5) , 1146-1154
- https://doi.org/10.1161/01.cir.76.5.1146
Abstract
This study was designed to test the hypothesis that verapamil has an effect on ischemia-initiated arrhythmias related to its regional influences on recovery of excitability and conduction time. Using a coronary perfused preparation of cat left ventricle that allows simultaneous electrophysiologic monitoring of both endocardium and epicardium, we studied the effect of verapamil on ischemia-induced changes in transmembrane action potentials, conduction properties, and refractory periods of endocardial and epicardial muscle cells. Oxygenated Tyrode's solution was perfused through the left anterior descending coronary artery, while the preparation was superfused with Tyrode's solution gassed with 95% N2 and 5% CO2. "Ischemia" was produced by stopping coronary perfusion. During 30 min of ischemia, resting potential, action potential amplitude (APA), and action potential duration (APD) were reduced, and conduction time was prolonged in both endocardial and epicardial cells, but the changes were greater in the epicardial cells. Endocardial refractory periods shortened in parallel with APD shortening throughout 30 min of ischemia, whereas epicardial refractory periods shortened for the first 10 min and then increased due to development of longer postrepolarization refractoriness. As a result, there were significant differences in refractory periods between endocardial and epicardial cells at 10 and 30 min of ischemia, and rapid ventricular activity could be induced at these times. Exposure to verapamil (1 mg/liter) before cessation of coronary perfusion significantly limited the reduction of APA and the prolongation of conduction time during the first 10 min of ischemia in epicardial cells, but did not influence endocardial cells. During the remaining 20 min of ischemia, verapamil enhanced the reduction of APD of both epicardial and endocardial cells.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 18 references indexed in Scilit:
- Cellular electrophysiologic changes and “arrhythmias” during experimental ischemia and reperfusion in isolated cat ventricular myocardiumJournal of the American College of Cardiology, 1986
- Effects of Verapamil and Lidocaine on Changes in Action Potential Characteristics and Conduction Time Induced by Combined Hypoxia, Hyperkalemia, and Acidosis in Canine Ventricular MyocardiumJournal of Cardiovascular Pharmacology, 1982
- Effects of calcium antagonists on coronary circulation and conduction delay induced by myocardial ischemia in dogs: A comparative study with other coronary vasodilatorsEuropean Journal of Pharmacology, 1981
- Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion: Comparative effects of verapamil and nifedipineThe American Journal of Cardiology, 1981
- Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardiumThe American Journal of Cardiology, 1980
- Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusionCardiovascular Research, 1980
- Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel".Circulation, 1979
- Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogsThe American Journal of Cardiology, 1977
- Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human atria.Circulation, 1976